Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Two-Stage, Non-randomized, Multi-center Within Patient Comparison Study to Evaluate the SENSE Device's Ability to Detect Intracranial Hemorrhage

NCT04642443 is registered in ClinicalTrials.gov with Sense Diagnostics, LLC as lead sponsor.

NCT NCT04642443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Two-Stage, Non-randomized, Multi-center Within Patient Comparison Study to Evaluate the SENSE Device's Ability to Detect Intracranial Hemorrhage
Lead sponsor
Sense Diagnostics, LLC
Phase
Not applicable
Overall status
Unknown status
Start date
December 23, 2020
Completion date
September 30, 2024
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial hemorrhages, traumatic brain injury